English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Parkinson's disease (PD) is a neurodegenerative associated with a significant, negative impact on quality of life, health care and societal costs . As the condition progresses the burden of disease in PD increases. Earlier identification of PD could provide the opportunity to intervene earlier, with evidence that this can delay the onset of the disease. Currently though an early identification test for PD does not exist. The aim of this work is to establish the feasibility and value of identifying biomarkers in PD which could form the basis of an early identification test.

trials

Research into biomarkers to facilitate the early identification of Parkinson's disease: a decision analytic model to determine the feasibility and value